_id
69130b61ccc777a4e85d7c86
Ticker
KPRX
Name
Kiora Pharmaceuticals Inc
Exchange
NASDAQ
Address
332 Encinitas Boulevard, Encinitas, CA, United States, 92024
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.kiorapharma.com
Description
Kiora Pharmaceuticals, Inc., a clinical-stage specialty pharmaceutical company, engages in the development and commercialization of therapies for the treatment of ophthalmic diseases. Its lead product is KIO-301, a potential vision-restoring small molecule, which is in Phase 2 clinical trials for the treatment of retinitis pigmentosa, choroideremia, and Stargardt disease. The company is also developing KIO-104, a non-steroidal, immuno-modulatory, small-molecule inhibitor of dihydroorotate dehydrogenase, which is in phase 1b/2a study for the treatment of posterior non-infectious uveitis, as well as under pre-clinical development for the treatment of proliferative vitreoretinopathy; and KIO-101, an eye drop formulation for the treatment of ocular presentation of rheumatoid arthritis. It has strategic development and commercialization agreement with Théa Open Innovation for the development of KIO-301; and collaboration and development agreement with Global Genes for treating rare ocular disorders. The company operates in the United States, Austria, and Australia. The company was formerly known as Eyegate Pharmaceuticals, Inc. and changed its name to Kiora Pharmaceuticals, Inc. in November 2021. Kiora Pharmaceuticals, Inc. was incorporated in 1998 and is headquartered in Encinitas, California.
Last Close
2.14
Volume
20549
Current Price
2.1279
Change
-0.5654205607476739
Last Updated
2025-12-01T10:00:15.327Z
Image
data:image/webp;base64,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
Ipo Date
2015-07-31T00:00:00.000Z
Market Cap
7282311
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0
Sentiment Sources
1
Rating
4
Target Price
12
Strong Buy
0
Buy
2
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
38235
Gross Profit
-38235
Operating Expenses
2477235
Operating Income
-2515470
Interest Expense
-
Pretax Income
-616323
Net Income
26806
Eps
0.006145712490886665
Dividends Per Share
-
Shares Outstanding
3677935
Income Tax Expense
-643129
EBITDA
-578088
Operating Margin
-
Total Other Income Expense Net
1899147
Cash
5508899
Short Term Investments
13866546
Receivables
1213226
Inventories
-
Total Current Assets
22693856
Property Plant Equipment
419843
Total Assets
29863454
Payables
241471
Short Term Debt
155926
Long Term Debt
-
Total Liabilities
7452712
Equity
22410742
Depreciation
38235
Change In Working Capital
87027
Cash From Operations
-1273088
Capital Expenditures
432
Cash From Investing
5740569
Cash From Financing
0
Net Change In Cash
4480575
PE
-
PB
0.41414722216694116
ROE
0.11961228235995042
ROA
0.08976188755661016
FCF
-1273520
Fcf Percent
-
Piotroski FScore
2
Health Score
56
Deep Value Investing Score
9.5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
5.8
Garp Investing Score
2
Growth Investing Score
0.5
Momentum Investing Score
3
Net Net Investing Score
7.5
Quality Investing Score
5
Value Investing Score
8
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
38235
Quarters > 0 > income Statement > gross Profit
-38235
Quarters > 0 > income Statement > operating Expenses
2477235
Quarters > 0 > income Statement > operating Income
-2515470
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-616323
Quarters > 0 > income Statement > net Income
26806
Quarters > 0 > income Statement > eps
0.006145712490886665
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
4361740
Quarters > 0 > income Statement > income Tax Expense
-643129
Quarters > 0 > income Statement > EBITDA
-578088
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
1899147
Quarters > 0 > balance Sheet > cash
5508899
Quarters > 0 > balance Sheet > short Term Investments
13866546
Quarters > 0 > balance Sheet > receivables
1213226
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
22693856
Quarters > 0 > balance Sheet > property Plant Equipment
419843
Quarters > 0 > balance Sheet > total Assets
29863454
Quarters > 0 > balance Sheet > payables
241471
Quarters > 0 > balance Sheet > short Term Debt
155926
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
7452712
Quarters > 0 > balance Sheet > equity
22410742
Quarters > 0 > cash Flow > net Income
26806
Quarters > 0 > cash Flow > depreciation
38235
Quarters > 0 > cash Flow > change In Working Capital
87027
Quarters > 0 > cash Flow > cash From Operations
-1273088
Quarters > 0 > cash Flow > capital Expenditures
432
Quarters > 0 > cash Flow > cash From Investing
5740569
Quarters > 0 > cash Flow > cash From Financing
0
Quarters > 0 > cash Flow > net Change In Cash
4480575
Quarters > 0 > ratios > PE
0.006145712490886665
Quarters > 0 > ratios > PB
0.41414722216694116
Quarters > 0 > ratios > ROE
0.11961228235995042
Quarters > 0 > ratios > ROA
0.08976188755661016
Quarters > 0 > ratios > FCF
-1273520
Quarters > 0 > ratios > Piotroski FScore
2
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
56
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
31496
Quarters > 1 > income Statement > gross Profit
-31496
Quarters > 1 > income Statement > operating Expenses
2396197
Quarters > 1 > income Statement > operating Income
-2396197
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-2264516
Quarters > 1 > income Statement > net Income
-2152459
Quarters > 1 > income Statement > eps
-0.5395929649274187
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
3989042
Quarters > 1 > income Statement > income Tax Expense
-112057
Quarters > 1 > income Statement > EBITDA
-2254999
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
131681
Quarters > 1 > balance Sheet > cash
1028324
Quarters > 1 > balance Sheet > short Term Investments
19637812
Quarters > 1 > balance Sheet > receivables
3114024
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
24737255
Quarters > 1 > balance Sheet > property Plant Equipment
455860
Quarters > 1 > balance Sheet > total Assets
31945683
Quarters > 1 > balance Sheet > payables
282537
Quarters > 1 > balance Sheet > short Term Debt
143327
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
9818207
Quarters > 1 > balance Sheet > equity
22127476
Quarters > 1 > cash Flow > net Income
-2152459
Quarters > 1 > cash Flow > depreciation
3423
Quarters > 1 > cash Flow > change In Working Capital
-2072558
Quarters > 1 > cash Flow > cash From Operations
-3803434
Quarters > 1 > cash Flow > capital Expenditures
32195
Quarters > 1 > cash Flow > cash From Investing
664172
Quarters > 1 > cash Flow > cash From Financing
265359
Quarters > 1 > cash Flow > net Change In Cash
-2742320
Quarters > 1 > ratios > PE
-0.5395929649274187
Quarters > 1 > ratios > PB
0.3836082557179138
Quarters > 1 > ratios > ROE
-9.72753964347312
Quarters > 1 > ratios > ROA
-6.737871279822065
Quarters > 1 > ratios > FCF
-3835629
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
41
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
19608
Quarters > 2 > income Statement > gross Profit
-19608
Quarters > 2 > income Statement > operating Expenses
2330354
Quarters > 2 > income Statement > operating Income
-2330354
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-2069974
Quarters > 2 > income Statement > net Income
-2192980
Quarters > 2 > income Statement > eps
-0.5200323357300569
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
4217007
Quarters > 2 > income Statement > income Tax Expense
123006
Quarters > 2 > income Statement > EBITDA
-2054844
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
260380
Quarters > 2 > balance Sheet > cash
3771024
Quarters > 2 > balance Sheet > short Term Investments
20334831
Quarters > 2 > balance Sheet > receivables
2059894
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
27107291
Quarters > 2 > balance Sheet > property Plant Equipment
157067
Quarters > 2 > balance Sheet > total Assets
34019862
Quarters > 2 > balance Sheet > payables
942492
Quarters > 2 > balance Sheet > short Term Debt
71554
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
10319475
Quarters > 2 > balance Sheet > equity
23700387
Quarters > 2 > cash Flow > net Income
-2192980
Quarters > 2 > cash Flow > depreciation
318
Quarters > 2 > cash Flow > change In Working Capital
-930682
Quarters > 2 > cash Flow > cash From Operations
-2704199
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
2672782
Quarters > 2 > cash Flow > cash From Financing
0
Quarters > 2 > cash Flow > net Change In Cash
-21274
Quarters > 2 > ratios > PE
-0.5200323357300569
Quarters > 2 > ratios > PB
0.37861699031749985
Quarters > 2 > ratios > ROE
-9.252929076643348
Quarters > 2 > ratios > ROA
-6.44617547243431
Quarters > 2 > ratios > FCF
-2704199
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
41
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
-15951822
Quarters > 3 > income Statement > cost Of Revenue
34089
Quarters > 3 > income Statement > gross Profit
-15985911
Quarters > 3 > income Statement > operating Expenses
2564682
Quarters > 3 > income Statement > operating Income
-2564682
Quarters > 3 > income Statement > interest Expense
21446
Quarters > 3 > income Statement > pretax Income
-2158497
Quarters > 3 > income Statement > net Income
-4223502
Quarters > 3 > income Statement > eps
-1.4074643060422796
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
3000788
Quarters > 3 > income Statement > income Tax Expense
2065005
Quarters > 3 > income Statement > EBITDA
-2399923
Quarters > 3 > income Statement > operating Margin
16.077674387289427
Quarters > 3 > income Statement > total Other Income Expense Net
406185
Quarters > 3 > balance Sheet > cash
3792322
Quarters > 3 > balance Sheet > short Term Investments
22999760
Quarters > 3 > balance Sheet > receivables
601197
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
29706012
Quarters > 3 > balance Sheet > property Plant Equipment
62402
Quarters > 3 > balance Sheet > total Assets
36484484
Quarters > 3 > balance Sheet > payables
415590
Quarters > 3 > balance Sheet > short Term Debt
23355
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
10724708
Quarters > 3 > balance Sheet > equity
25759776
Quarters > 3 > cash Flow > net Income
-4223502
Quarters > 3 > cash Flow > depreciation
5912
Quarters > 3 > cash Flow > change In Working Capital
2103371
Quarters > 3 > cash Flow > cash From Operations
-2252358
Quarters > 3 > cash Flow > capital Expenditures
45031
Quarters > 3 > cash Flow > cash From Investing
482683
Quarters > 3 > cash Flow > cash From Financing
0
Quarters > 3 > cash Flow > net Change In Cash
-1845160
Quarters > 3 > ratios > PE
-1.4074643060422796
Quarters > 3 > ratios > PB
0.24788168907990502
Quarters > 3 > ratios > ROE
-16.39572486965725
Quarters > 3 > ratios > ROA
-11.576159333923977
Quarters > 3 > ratios > FCF
-2297389
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
0.14402047615626604
Quarters > 3 > health Score
46
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
16000000
Annuals > 0 > income Statement > cost Of Revenue
379508
Annuals > 0 > income Statement > gross Profit
16000000
Annuals > 0 > income Statement > operating Expenses
11489712
Annuals > 0 > income Statement > operating Income
4510288
Annuals > 0 > income Statement > interest Expense
21446
Annuals > 0 > income Statement > pretax Income
5659738
Annuals > 0 > income Statement > net Income
3594733
Annuals > 0 > income Statement > eps
0.8714345799773338
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
4125075
Annuals > 0 > income Statement > income Tax Expense
2065005
Annuals > 0 > income Statement > EBITDA
5700389
Annuals > 0 > income Statement > operating Margin
28.1893
Annuals > 0 > income Statement > total Other Income Expense Net
1149450
Annuals > 0 > balance Sheet > cash
3792322
Annuals > 0 > balance Sheet > short Term Investments
22999760
Annuals > 0 > balance Sheet > receivables
601197
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
29706012
Annuals > 0 > balance Sheet > property Plant Equipment
62402
Annuals > 0 > balance Sheet > total Assets
36484484
Annuals > 0 > balance Sheet > payables
415590
Annuals > 0 > balance Sheet > short Term Debt
23355
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
10724708
Annuals > 0 > balance Sheet > equity
25759776
Annuals > 0 > cash Flow > net Income
3594733
Annuals > 0 > cash Flow > depreciation
19205
Annuals > 0 > cash Flow > change In Working Capital
3666061
Annuals > 0 > cash Flow > cash From Operations
8559115
Annuals > 0 > cash Flow > capital Expenditures
6256
Annuals > 0 > cash Flow > cash From Investing
-22662611
Annuals > 0 > cash Flow > cash From Financing
15498155
Annuals > 0 > cash Flow > net Change In Cash
1337428
Annuals > 0 > ratios > PE
0.8714345799773338
Annuals > 0 > ratios > PB
0.3170698572844733
Annuals > 0 > ratios > ROE
13.954830197281218
Annuals > 0 > ratios > ROA
9.85277193450235
Annuals > 0 > ratios > FCF
8552859
Annuals > 0 > ratios > Piotroski FScore
4
Annuals > 0 > ratios > fcf Percent
0.5345536875
Annuals > 0 > health Score
89
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
4027037
Annuals > 1 > income Statement > gross Profit
-4027037
Annuals > 1 > income Statement > operating Expenses
12586896
Annuals > 1 > income Statement > operating Income
-12586896
Annuals > 1 > income Statement > interest Expense
11132
Annuals > 1 > income Statement > pretax Income
-12423577
Annuals > 1 > income Statement > net Income
-12513896
Annuals > 1 > income Statement > eps
-23.25972710392244
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
538007
Annuals > 1 > income Statement > income Tax Expense
90319
Annuals > 1 > income Statement > EBITDA
-12360647
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
163319
Annuals > 1 > balance Sheet > cash
2454684
Annuals > 1 > balance Sheet > short Term Investments
0
Annuals > 1 > balance Sheet > receivables
2049965
Annuals > 1 > balance Sheet > inventories
1
Annuals > 1 > balance Sheet > total Current Assets
4738031
Annuals > 1 > balance Sheet > property Plant Equipment
114954
Annuals > 1 > balance Sheet > total Assets
13711870
Annuals > 1 > balance Sheet > payables
206260
Annuals > 1 > balance Sheet > short Term Debt
47069
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
7602216
Annuals > 1 > balance Sheet > equity
6109654
Annuals > 1 > cash Flow > net Income
-12513896
Annuals > 1 > cash Flow > depreciation
51798
Annuals > 1 > cash Flow > change In Working Capital
-1821952
Annuals > 1 > cash Flow > cash From Operations
-9556951
Annuals > 1 > cash Flow > capital Expenditures
1
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
5966066
Annuals > 1 > cash Flow > net Change In Cash
-3554865
Annuals > 1 > ratios > PE
-23.25972710392244
Annuals > 1 > ratios > PB
0.1743558407726526
Annuals > 1 > ratios > ROE
-204.82168057307337
Annuals > 1 > ratios > ROA
-91.26323397173398
Annuals > 1 > ratios > FCF
-9556952
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
24
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
134028
Annuals > 2 > income Statement > gross Profit
-134028
Annuals > 2 > income Statement > operating Expenses
12309523
Annuals > 2 > income Statement > operating Income
-12309523
Annuals > 2 > income Statement > interest Expense
8599
Annuals > 2 > income Statement > pretax Income
-13696620
Annuals > 2 > income Statement > net Income
-13583610
Annuals > 2 > income Statement > eps
-18.549166123858566
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
732303
Annuals > 2 > income Statement > income Tax Expense
-113010
Annuals > 2 > income Statement > EBITDA
-13646412
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
-1387097
Annuals > 2 > balance Sheet > cash
5964556
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
1373041
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
7680666
Annuals > 2 > balance Sheet > property Plant Equipment
172169
Annuals > 2 > balance Sheet > total Assets
18678259
Annuals > 2 > balance Sheet > payables
1008262
Annuals > 2 > balance Sheet > short Term Debt
105782
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
7270659
Annuals > 2 > balance Sheet > equity
11407600
Annuals > 2 > cash Flow > net Income
-13583610
Annuals > 2 > cash Flow > depreciation
41609
Annuals > 2 > cash Flow > change In Working Capital
668513
Annuals > 2 > cash Flow > cash From Operations
-10428133
Annuals > 2 > cash Flow > capital Expenditures
0
Annuals > 2 > cash Flow > cash From Investing
6375
Annuals > 2 > cash Flow > cash From Financing
8620921
Annuals > 2 > cash Flow > net Change In Cash
-1885874
Annuals > 2 > ratios > PE
-18.549166123858566
Annuals > 2 > ratios > PB
0.12710473193309724
Annuals > 2 > ratios > ROE
-119.07509029068339
Annuals > 2 > ratios > ROA
-72.72417627360237
Annuals > 2 > ratios > FCF
-10428133
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
29
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
12059
Annuals > 3 > income Statement > cost Of Revenue
227273
Annuals > 3 > income Statement > gross Profit
-227273
Annuals > 3 > income Statement > operating Expenses
14235768
Annuals > 3 > income Statement > operating Income
-14235768
Annuals > 3 > income Statement > interest Expense
6851
Annuals > 3 > income Statement > pretax Income
-13963288
Annuals > 3 > income Statement > net Income
-13770685
Annuals > 3 > income Statement > eps
-57.11630906805918
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
241099
Annuals > 3 > income Statement > income Tax Expense
-192603
Annuals > 3 > income Statement > EBITDA
-13911141
Annuals > 3 > income Statement > operating Margin
-118050.98266854632
Annuals > 3 > income Statement > total Other Income Expense Net
272480
Annuals > 3 > balance Sheet > cash
7854690
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
529560
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
8990770
Annuals > 3 > balance Sheet > property Plant Equipment
283410
Annuals > 3 > balance Sheet > total Assets
20130308
Annuals > 3 > balance Sheet > payables
160621
Annuals > 3 > balance Sheet > short Term Debt
118846
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
5551260
Annuals > 3 > balance Sheet > equity
14579048
Annuals > 3 > cash Flow > net Income
-13770685
Annuals > 3 > cash Flow > depreciation
45296
Annuals > 3 > cash Flow > change In Working Capital
-1035796
Annuals > 3 > cash Flow > cash From Operations
-10675390
Annuals > 3 > cash Flow > capital Expenditures
63865
Annuals > 3 > cash Flow > cash From Investing
-157020
Annuals > 3 > cash Flow > cash From Financing
17582926
Annuals > 3 > cash Flow > net Change In Cash
6669013
Annuals > 3 > ratios > PE
-57.11630906805918
Annuals > 3 > ratios > PB
0.03274397752171473
Annuals > 3 > ratios > ROE
-94.4553101135273
Annuals > 3 > ratios > ROA
-68.40772133243068
Annuals > 3 > ratios > FCF
-10739255
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-890.5593332780496
Annuals > 3 > health Score
33
Valuation > metrics > PE
0.006145712490886665
Valuation > metrics > PB
0.41414722216694116
Valuation > final Score
90
Valuation > verdict
79.3% Undervalued
Profitability > metrics > ROE
0.11961228235995042
Profitability > metrics > ROA
0.11812007620036014
Profitability > final Score
16
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.3325508811801055
Risk > metrics > Interest Coverage
-65.78972145939584
Risk > final Score
-203
Risk > verdict
High
Liquidity > metrics > Current Ratio
57.106258980314394
Liquidity > metrics > Quick Ratio
57.106258980314394
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
70
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
30
Prev Risks > 0
-947
Prev Risks > 1
-556
Prev Risks > 2
-418
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-13T00:56:15.884Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-17
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0.01
Earnings History > 0 > eps Estimate
-0.72
Earnings History > 0 > eps Difference
0.73
Earnings History > 0 > surprise Percent
101.3889
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-08
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.54
Earnings History > 1 > eps Estimate
-0.06
Earnings History > 1 > eps Difference
-0.48
Earnings History > 1 > surprise Percent
-800
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-08
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
BeforeMarket
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-0.52
Earnings History > 2 > eps Estimate
-0.77
Earnings History > 2 > eps Difference
0.25
Earnings History > 2 > surprise Percent
32.4675
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-03-24
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-1.2076
Earnings History > 3 > eps Estimate
-0.74
Earnings History > 3 > eps Difference
-0.4676
Earnings History > 3 > surprise Percent
-63.1892
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-07
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.81
Earnings History > 4 > eps Estimate
-0.76
Earnings History > 4 > eps Difference
-0.05
Earnings History > 4 > surprise Percent
-6.5789
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-09
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.53
Earnings History > 5 > eps Estimate
-0.86
Earnings History > 5 > eps Difference
0.33
Earnings History > 5 > surprise Percent
38.3721
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-10
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
BeforeMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
0.38
Earnings History > 6 > eps Estimate
-0.07
Earnings History > 6 > eps Difference
0.45
Earnings History > 6 > surprise Percent
642.8571
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-03-25
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.47
Earnings History > 7 > eps Estimate
-0.42
Earnings History > 7 > eps Difference
-0.05
Earnings History > 7 > surprise Percent
-11.9048
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-09
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
BeforeMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.89
Earnings History > 8 > eps Estimate
-0.35
Earnings History > 8 > eps Difference
-0.54
Earnings History > 8 > surprise Percent
-154.2857
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-08-08
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
BeforeMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.79
Earnings History > 9 > eps Estimate
-1.07
Earnings History > 9 > eps Difference
0.28
Earnings History > 9 > surprise Percent
26.1682
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-09
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
BeforeMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-1
Earnings History > 10 > eps Estimate
-1.68
Earnings History > 10 > eps Difference
0.68
Earnings History > 10 > surprise Percent
40.4762
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-03-23
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
BeforeMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-1.76
Earnings History > 11 > eps Estimate
-2.46
Earnings History > 11 > eps Difference
0.7
Earnings History > 11 > surprise Percent
28.4553
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-11-09
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
BeforeMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-6.03
Earnings History > 12 > eps Estimate
-3.83
Earnings History > 12 > eps Difference
-2.2
Earnings History > 12 > surprise Percent
-57.4413
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-08-12
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
BeforeMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-7.2
Earnings History > 13 > eps Estimate
-8
Earnings History > 13 > eps Difference
0.8
Earnings History > 13 > surprise Percent
10
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-04-15
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
BeforeMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-26.47
Earnings History > 14 > eps Estimate
-9.2
Earnings History > 14 > eps Difference
-17.27
Earnings History > 14 > surprise Percent
-187.7174
Earnings History > 15 > period
2021-12-31
Earnings History > 15 > report Date
2022-03-02
Earnings History > 15 > date
2021-12-31
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.66
Earnings History > 15 > eps Estimate
-0.3
Earnings History > 15 > eps Difference
-0.36
Earnings History > 15 > surprise Percent
-120
Earnings History > 16 > period
2021-09-30
Earnings History > 16 > report Date
2021-11-15
Earnings History > 16 > date
2021-09-30
Earnings History > 16 > before After Market
BeforeMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-11.6
Earnings History > 16 > eps Estimate
-13.47
Earnings History > 16 > eps Difference
1.87
Earnings History > 16 > surprise Percent
13.8827
Earnings History > 17 > period
2021-06-30
Earnings History > 17 > report Date
2021-08-12
Earnings History > 17 > date
2021-06-30
Earnings History > 17 > before After Market
AfterMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-14
Earnings History > 17 > eps Estimate
-16.67
Earnings History > 17 > eps Difference
2.67
Earnings History > 17 > surprise Percent
16.0168
Earnings History > 18 > period
2021-03-31
Earnings History > 18 > report Date
2021-05-12
Earnings History > 18 > date
2021-03-31
Earnings History > 18 > before After Market
AfterMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-14.8
Earnings History > 18 > eps Estimate
-15.4
Earnings History > 18 > eps Difference
0.6
Earnings History > 18 > surprise Percent
3.8961
Earnings History > 19 > period
2020-12-31
Earnings History > 19 > report Date
2021-03-25
Earnings History > 19 > date
2020-12-31
Earnings History > 19 > before After Market
AfterMarket
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-20.8
Earnings History > 19 > eps Estimate
-17.6
Earnings History > 19 > eps Difference
-3.2
Earnings History > 19 > surprise Percent
-18.1818
Earnings History > 20 > period
2020-09-30
Earnings History > 20 > report Date
2020-11-09
Earnings History > 20 > date
2020-09-30
Earnings History > 20 > before After Market
AfterMarket
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-17.6
Earnings History > 20 > eps Estimate
-16.8
Earnings History > 20 > eps Difference
-0.8
Earnings History > 20 > surprise Percent
-4.7619
Earnings History > 21 > period
2020-06-30
Earnings History > 21 > report Date
2020-08-06
Earnings History > 21 > date
2020-06-30
Earnings History > 21 > before After Market
AfterMarket
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-15.2
Earnings History > 21 > eps Estimate
-17.2
Earnings History > 21 > eps Difference
2
Earnings History > 21 > surprise Percent
11.6279
Earnings History > 22 > period
2020-03-31
Earnings History > 22 > report Date
2020-05-06
Earnings History > 22 > date
2020-03-31
Earnings History > 22 > before After Market
AfterMarket
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-0.43
Earnings History > 22 > eps Estimate
-
Earnings History > 22 > eps Difference
0
Earnings History > 22 > surprise Percent
-
Earnings History > 23 > period
2019-12-31
Earnings History > 23 > report Date
2020-03-04
Earnings History > 23 > date
2019-12-31
Earnings History > 23 > before After Market
AfterMarket
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
-28.6
Earnings History > 23 > eps Estimate
-32.4
Earnings History > 23 > eps Difference
3.8
Earnings History > 23 > surprise Percent
11.7284
Earnings History > 24 > period
2019-09-30
Earnings History > 24 > report Date
2019-11-07
Earnings History > 24 > date
2019-09-30
Earnings History > 24 > before After Market
BeforeMarket
Earnings History > 24 > currency
USD
Earnings History > 24 > eps Actual
-1.15
Earnings History > 24 > eps Estimate
-0.75
Earnings History > 24 > eps Difference
-0.4
Earnings History > 24 > surprise Percent
-53.3333
Earnings History > 25 > period
2019-06-30
Earnings History > 25 > report Date
2019-08-08
Earnings History > 25 > date
2019-06-30
Earnings History > 25 > before After Market
BeforeMarket
Earnings History > 25 > currency
USD
Earnings History > 25 > eps Actual
-24
Earnings History > 25 > eps Estimate
-30
Earnings History > 25 > eps Difference
6
Earnings History > 25 > surprise Percent
20
Earnings History > 26 > period
2019-03-31
Earnings History > 26 > report Date
2019-05-08
Earnings History > 26 > date
2019-03-31
Earnings History > 26 > before After Market
AfterMarket
Earnings History > 26 > currency
USD
Earnings History > 26 > eps Actual
6
Earnings History > 26 > eps Estimate
-30
Earnings History > 26 > eps Difference
36
Earnings History > 26 > surprise Percent
120
Earnings History > 27 > period
2018-12-31
Earnings History > 27 > report Date
2019-03-01
Earnings History > 27 > date
2018-12-31
Earnings History > 27 > before After Market
AfterMarket
Earnings History > 27 > currency
USD
Earnings History > 27 > eps Actual
-30
Earnings History > 27 > eps Estimate
-36
Earnings History > 27 > eps Difference
6
Earnings History > 27 > surprise Percent
16.6667
Earnings History > 28 > period
2018-09-30
Earnings History > 28 > report Date
2018-11-13
Earnings History > 28 > date
2018-09-30
Earnings History > 28 > before After Market
AfterMarket
Earnings History > 28 > currency
USD
Earnings History > 28 > eps Actual
-42
Earnings History > 28 > eps Estimate
-48
Earnings History > 28 > eps Difference
6
Earnings History > 28 > surprise Percent
12.5
Earnings History > 29 > period
2018-06-30
Earnings History > 29 > report Date
2018-08-03
Earnings History > 29 > date
2018-06-30
Earnings History > 29 > before After Market
BeforeMarket
Earnings History > 29 > currency
USD
Earnings History > 29 > eps Actual
-42
Earnings History > 29 > eps Estimate
-84
Earnings History > 29 > eps Difference
42
Earnings History > 29 > surprise Percent
50
Earnings History > 30 > period
2018-03-31
Earnings History > 30 > report Date
2018-05-11
Earnings History > 30 > date
2018-03-31
Earnings History > 30 > before After Market
BeforeMarket
Earnings History > 30 > currency
USD
Earnings History > 30 > eps Actual
-84
Earnings History > 30 > eps Estimate
-144
Earnings History > 30 > eps Difference
60
Earnings History > 30 > surprise Percent
41.6667
Earnings History > 31 > period
2017-12-31
Earnings History > 31 > report Date
2018-03-02
Earnings History > 31 > date
2017-12-31
Earnings History > 31 > before After Market
AfterMarket
Earnings History > 31 > currency
USD
Earnings History > 31 > eps Actual
-90
Earnings History > 31 > eps Estimate
-144
Earnings History > 31 > eps Difference
54
Earnings History > 31 > surprise Percent
37.5
Earnings History > 32 > period
2017-09-30
Earnings History > 32 > report Date
2017-11-14
Earnings History > 32 > date
2017-09-30
Earnings History > 32 > before After Market
BeforeMarket
Earnings History > 32 > currency
USD
Earnings History > 32 > eps Actual
-144
Earnings History > 32 > eps Estimate
-129
Earnings History > 32 > eps Difference
-15
Earnings History > 32 > surprise Percent
-11.6279
Earnings History > 33 > period
2017-06-30
Earnings History > 33 > report Date
2017-08-04
Earnings History > 33 > date
2017-06-30
Earnings History > 33 > before After Market
AfterMarket
Earnings History > 33 > currency
USD
Earnings History > 33 > eps Actual
-168
Earnings History > 33 > eps Estimate
-118
Earnings History > 33 > eps Difference
-50
Earnings History > 33 > surprise Percent
-42.3729
Earnings History > 34 > period
2017-03-31
Earnings History > 34 > report Date
2017-05-05
Earnings History > 34 > date
2017-03-31
Earnings History > 34 > before After Market
AfterMarket
Earnings History > 34 > currency
USD
Earnings History > 34 > eps Actual
-168
Earnings History > 34 > eps Estimate
-234
Earnings History > 34 > eps Difference
66
Earnings History > 34 > surprise Percent
28.2051
Earnings History > 35 > period
2016-12-31
Earnings History > 35 > report Date
2017-02-23
Earnings History > 35 > date
2016-12-31
Earnings History > 35 > before After Market
AfterMarket
Earnings History > 35 > currency
USD
Earnings History > 35 > eps Actual
-228
Earnings History > 35 > eps Estimate
-254
Earnings History > 35 > eps Difference
26
Earnings History > 35 > surprise Percent
10.2362
Earnings History > 36 > period
2016-09-30
Earnings History > 36 > report Date
2016-11-01
Earnings History > 36 > date
2016-09-30
Earnings History > 36 > before After Market
AfterMarket
Earnings History > 36 > currency
USD
Earnings History > 36 > eps Actual
-216
Earnings History > 36 > eps Estimate
-276
Earnings History > 36 > eps Difference
60
Earnings History > 36 > surprise Percent
21.7391
Earnings History > 37 > period
2016-06-30
Earnings History > 37 > report Date
2016-08-10
Earnings History > 37 > date
2016-06-30
Earnings History > 37 > before After Market
AfterMarket
Earnings History > 37 > currency
USD
Earnings History > 37 > eps Actual
-276
Earnings History > 37 > eps Estimate
-186
Earnings History > 37 > eps Difference
-90
Earnings History > 37 > surprise Percent
-48.3871
Earnings History > 38 > period
2016-03-31
Earnings History > 38 > report Date
2016-05-13
Earnings History > 38 > date
2016-03-31
Earnings History > 38 > before After Market
AfterMarket
Earnings History > 38 > currency
USD
Earnings History > 38 > eps Actual
-186
Earnings History > 38 > eps Estimate
-151.5
Earnings History > 38 > eps Difference
-34.5
Earnings History > 38 > surprise Percent
-22.7723
Earnings History > 39 > period
2015-12-31
Earnings History > 39 > report Date
2016-03-29
Earnings History > 39 > date
2015-12-31
Earnings History > 39 > before After Market
AfterMarket
Earnings History > 39 > currency
USD
Earnings History > 39 > eps Actual
-144
Earnings History > 39 > eps Estimate
-116
Earnings History > 39 > eps Difference
-28
Earnings History > 39 > surprise Percent
-24.1379
Earnings History > 40 > period
2015-09-30
Earnings History > 40 > report Date
2015-11-12
Earnings History > 40 > date
2015-09-30
Earnings History > 40 > before After Market
BeforeMarket
Earnings History > 40 > currency
USD
Earnings History > 40 > eps Actual
-2.8391
Earnings History > 40 > eps Estimate
-
Earnings History > 40 > eps Difference
0
Earnings History > 40 > surprise Percent
-
Earnings History > 41 > period
2015-06-30
Earnings History > 41 > report Date
2015-08-12
Earnings History > 41 > date
2015-06-30
Earnings History > 41 > before After Market
BeforeMarket
Earnings History > 41 > currency
USD
Earnings History > 41 > eps Actual
-3.6335
Earnings History > 41 > eps Estimate
-
Earnings History > 41 > eps Difference
0
Earnings History > 41 > surprise Percent
-
Earnings History > 42 > period
2015-03-31
Earnings History > 42 > report Date
2015-05-15
Earnings History > 42 > date
2015-03-31
Earnings History > 42 > before After Market
BeforeMarket
Earnings History > 42 > currency
USD
Earnings History > 42 > eps Actual
-9.3965
Earnings History > 42 > eps Estimate
-
Earnings History > 42 > eps Difference
0
Earnings History > 42 > surprise Percent
-
Kiora Pharmaceuticals, Inc., a clinical-stage specialty pharmaceutical company, engages in the development and commercialization of therapies for the treatment of ophthalmic diseases. Its lead product is KIO-301, a potential vision-restoring small molecule, which is in Phase 2 clinical trials for the treatment of retinitis pigmentosa, choroideremia, and Stargardt disease. The company is also developing KIO-104, a non-steroidal, immuno-modulatory, small-molecule inhibitor of dihydroorotate dehydrogenase, which is in phase 1b/2a study for the treatment of posterior non-infectious uveitis, as well as under pre-clinical development for the treatment of proliferative vitreoretinopathy; and KIO-101, an eye drop formulation for the treatment of ocular presentation of rheumatoid arthritis. It has strategic development and commercialization agreement with Théa Open Innovation for the development of KIO-301; and collaboration and development agreement with Global Genes for treating rare ocular disorders. The company operates in the United States, Austria, and Australia. The company was formerly known as Eyegate Pharmaceuticals, Inc. and changed its name to Kiora Pharmaceuticals, Inc. in November 2021. Kiora Pharmaceuticals, Inc. was incorporated in 1998 and is headquartered in Encinitas, California.
Stock Price
$ 0.00
0% decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ARSI Check: Can Appian Corporation stock resist market sell offs - 2025 Market Outlook & Accurate Entry and Exit Point Alerts moha.gov.vn
Read more →Kiora Pharma (NASDAQ: KPRX) wins US patent amid Phase 2 KIO-104 eye study Stock Titan
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
BUY
Target Price:
$12
Analyst Picks
Strong Buy
0
Buy
2
Hold
0
Sell
0
Strong Sell
0
Sentiment:
Neutral
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 28.06% of the total shares of Kiora Pharmaceuticals Inc
1.
AIGH Capital Management, LLC(6.301%)
since
2025/06/30
2.
Nantahala Capital Management, LLC(6.1486%)
since
2025/06/30
3.
Stonepine Capital Management Llc(5.1842%)
since
2025/06/30
4.
ADAR1 Capital Management LLC(4.8671%)
since
2025/06/30
5.
Velan Capital Investment Management LP(3.5597%)
since
2025/06/30
6.
Geode Capital Management, LLC(0.5409%)
since
2025/06/30
7.
UBS Group AG(0.5139%)
since
2025/06/30
8.
Fidelity Extended Market Index(0.4045%)
since
2025/07/31
9.
Fidelity Series Total Market Index(0.1004%)
since
2025/07/31
10.
NT Ext Equity Mkt Idx Fd - L(0.0776%)
since
2025/06/30
11.
Northern Trust Extended Eq Market Idx(0.0776%)
since
2025/06/30
12.
Bridgeway Omni Small-Cap Value(0.0582%)
since
2025/06/30
13.
Bridgeway Omni Small-Cap Value N(0.0582%)
since
2025/06/30
14.
Vanguard Institutional Extnd Mkt Idx Tr(0.0546%)
since
2025/07/31
15.
NT Ext Eq Mkt Indx Fd DC Lending Tier 5(0.0219%)
since
2025/06/30
16.
Fidelity Total Market Index(0.0218%)
since
2025/07/31
17.
Spartan Total Market Index Pool G(0.0196%)
since
2025/07/31
18.
NT Ext Eq Mkt Indx Fd DC Lend T3(0.0185%)
since
2024/12/31
19.
Tower Research Capital LLC(0.0128%)
since
2025/06/30
20.
SBI Securities Co Ltd(0.0075%)
since
2025/06/30
21.
Spartan Extended Market Index Pool F(0.0029%)
since
2025/07/31
22.
BlackRock Inc(0.0017%)
since
2025/06/30
23.
Citigroup Inc(0.001%)
since
2025/06/30
24.
Goss Wealth Management LLC(0.0006%)
since
2025/06/30
25.
Bank of America Corp(0.0006%)
since
2025/06/30
26.
NT Ext Equity Mkt Idx Fd - NL(0.0003%)
since
2025/06/30
27.
NT Ext Equity Mkt Idx Fd - DC - NL - T2(0.0002%)
since
2025/06/30
28.
Advisor Group Holdings, Inc.(0.0001%)
since
2025/06/30
29.
Activest Wealth Management(0.0001%)
since
2025/06/30
30.
State St US Extended Mkt Indx NL Cl C(0.0001%)
since
2025/08/31
31.
SSgA U.S. Total Market Index Strategy(0.0001%)
since
2025/03/31
32.
Sabby Management LLC(0%)
since
2025/06/30
33.
Citadel Advisors Llc(0%)
since
2025/06/30
34.
Morgan Stanley - Brokerage Accounts(0%)
since
2025/06/30
35.
U.S. Bancorp(0%)
since
2025/03/31
36.
Rosalind Advisors, Inc.(0%)
since
2025/06/30
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
0.01
EPS Estimate
-0.72
EPS Difference
0.73
Surprise Percent
101.3889%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.